Sept 26 (Reuters) - Interleukin Genetics Inc, in a regulatory filing, said its Chief Financial Officer Thomas Gerson informed the company that he did not wish to continue his employment for personal reasons. The developer of preventive consumer products and genetic tests had named Gerson CFO on Sept 6. (Reporting by Purwa Khandelwal in Bangalore)
